Lipe & Dalton’s Accenture ACN Stock Holding History
Bought
Maintained
Sold
Other funds holding ACN
GA
AIM
WT
PTC
DC
Lipe & Dalton's ACN Position: Q2 2026 in Review
Lipe & Dalton sold out of Accenture (ACN) in Q2 2026, closing a stake of 2,077 shares — an estimated $412K sold.
Lipe & Dalton first reported a position in ACN in Q2 2019 and held it in 28 quarters. The position peaked at $1.99M in Q2 2025. 819 funds tracked by Wall St. Rank hold ACN as of Q2 2026.
- Lipe & Dalton reported no remaining Accenture position as of Q2 2026 after selling out during the quarter.
- Lipe & Dalton sold 2,077 Accenture shares in Q2 2026, an estimated $412K.
- Lipe & Dalton first reported a position in Accenture in Q2 2019 and held it in 28 quarters.
- Lipe & Dalton's Accenture position peaked at $1.99M in Q2 2025.
- 819 funds tracked by Wall St. Rank held Accenture as of Q2 2026.
Based on Lipe & Dalton's 13F filing for Q2 2026, filed 14 Jul 2026.